Stock Market

Cantor Fitzgerald Boosts United Therapeutics Price Forecast to $625

By Bullbit Editorial · March 28, 2026

WhatCantor Fitzgerald raised United Therapeutics price target to $625.
WhyAnalysts upgraded UTHR stock due to potential growth opportunities.
SignalThis price increase indicates increased investor confidence in the company.
TargetUnited Therapeutics may reach $625 per share based on Cantor Fitzgerald's forecast.
RiskInvestors should consider the potential risks associated with this upgraded price target.